INBIOGEN CO.,Ltd Logo

INBIOGEN CO.,Ltd

Data mining, bioinformatics, and virtual assistance for the life sciences industry.

101140 | KO

Overview

Corporate Details

ISIN(s):
KR7101140002
LEI:
Country:
South Korea
Address:
서울특별시 강남구 언주로135길 21 2층(논현동), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Inbiogen is a life sciences company focused on providing virtual assistance and data mining services to the biotechnology and pharmaceutical industries. The company leverages a team of scientists and bioinformatics specialists to offer a range of services, including bioinformatics analysis, protein modeling, custom database development, and virtual research assistance. It aims to help international biotech companies and research organizations address challenges by extracting valuable knowledge from large datasets. In addition to its core scientific services, Inbiogen also provides marketing assistance and web design and development tailored to the life sciences sector, focusing on delivering customized and cost-effective solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 749.8 KB
2025-07-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.5 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 831.3 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.4 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.0 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 12.4 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 395.1 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 19.5 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 148.6 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 115.1 KB
2025-03-12 00:00
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 20.0 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 12.3 KB
2025-01-22 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.6 KB
2025-01-10 00:00
Regulatory News Service
[기재정정]사업보고서 (2022.12)
Korean 442.9 KB
2025-01-10 00:00
Regulatory News Service
[기재정정]사업보고서 (2023.12)
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all INBIOGEN CO.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INBIOGEN CO.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INBIOGEN CO.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan
156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France
ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland
MDB
Medpace Holdings, Inc. Logo
Global CRO providing full-service clinical development to biotech, pharma & medical device industries.
United States of America
MEDP
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan
4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia
N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan
7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D

Talk to a Data Expert

Have a question? We'll get back to you promptly.